Accipiter Biosciences

Raised $12.7M in a Seed round, announced 6 November 2025.

Total raised: $12.7M

Latest round SeedCountry United StatesSector Health

Round

$12.7MSeed, 6 November 2025

Funds immunology and oncology pipeline work and up to two programs toward pre-IND.

Amount: $12.7M
Stage: Seed
Announced: 6 November 2025
Lead: Takeda
Other investors: Flying Fish Partners, Columbus Venture Partners, Cercano Capital, Washington Research Foundation, Alexandria Venture Investments
Use of funds: Funds immunology and oncology pipeline work and up to two programs toward pre-IND.
Checked: Announced by the company
Sources: Accipiter Biosciences raises $12.7M markets.financialcontent.com
Accipiter Biosciences raises $12.7M techstartups.com

Company

Designs de novo multifunctional protein biologics for complex diseases

Based in: Seattle, United States
Sector: Health
Website: accipiterbio.com ↗

Questions

How much has Accipiter Biosciences raised?

Accipiter Biosciences raised $12.7M in a Seed round, announced on 6 November 2025.

Who invested in Accipiter Biosciences?

Takeda led. Investors include Takeda, Flying Fish Partners, Columbus Venture Partners, Cercano Capital, Washington Research Foundation and Alexandria Venture Investments.